Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hodgkin Disease × Proton Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 14 Prostatic Neoplasms 13 Brain Neoplasms 11 Sarcoma 6 Meningioma 6 Glioma 6 Lung Neoplasms 5 Breast Neoplasms 5 Pancreatic Neoplasms 4 Neoplasms 4 Glioblastoma 4 Esophageal Neoplasms 4 Carcinoma, Hepatocellular 4 Squamous Cell Carcinoma of Head and Neck 3 Solid Tumor, Adult 3 Radiation Injuries 3 Liver Neoplasms 3 Head and Neck Neoplasms 3 Chondrosarcoma 3 Uterine Cervical Neoplasms 2 Thymus Neoplasms 2 Solid Tumor 2 Rhabdomyosarcoma 2 Prostate Adenocarcinoma 2 Pituitary Neoplasms 2 Oligodendroglioma 2 Nerve Sheath Neoplasms 2 Gliosarcoma 2 Ependymoma 2 Chordoma 2

Interventions

Cyclophosphamide 179 fludarabine phosphate 107 Etoposide 100 Peripheral Blood Stem Cell Transplantation 91 Filgrastim 83 Mycophenolic Acid 81 Doxorubicin 78 Whole-Body Irradiation 74 Melphalan 73 Brentuximab Vedotin 70 Radiotherapy 69 Tacrolimus 67 fludarabine 64 Busulfan 64 Vinblastine 59 Cyclosporine 58 Rituximab 56 Dacarbazine 49 Gemcitabine 48 Granulocyte Colony-Stimulating Factor 47 Bleomycin 47 Vincristine 43 Antilymphocyte Serum 43 Prednisone 41 Cytarabine 41 Nivolumab 40 Methotrexate 39 Carmustine 34 pembrolizumab 31 Sirolimus 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06883604 2025-03-19

PRO-Hodgkin

Uppsala University Hospital

Phase NA Recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡